Chronic lymphocytosis of functionally immature natural killer cells

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 4, 2007, Pages 924-931

  French, Anthony R ^a   Kim, Sungjin ^c   Fehniger, Todd A ^a   Pratt, Jennifer R ^c   Yang, Liping ^c   Song, Yun Jeong ^c   Caligiuri, Michael A ^b   Yokoyama, Wayne M ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

CD11b; chronic natural killer cell lymphocytosis; IL 15; lymphocytosis; Mac1; natural killer cell deficient mice; Natural killer cells

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; LEUCINE ZIPPER PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD; BONE MARROW; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE INSERTION; GENE LOCUS; HYPOTHESIS; LIVER; LYMPHOCYTOSIS; MIGRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE;

AGE FACTORS; ANIMALS; CHRONIC DISEASE; IMMUNOPHENOTYPING; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOCYTOSIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 34948910200     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.05.022     Document Type: Article

References (45)

1. Raulet D.H., Vance R.E., and McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 19 (2001) 291-330
2. Farag S.S., VanDeusen J.B., Fehniger T.A., and Caligiuri M.A. Biology and clinical impact of human natural killer cells. Int J Hematol 78 (2003) 7-17
3. Colucci F., Caligiuri M.A., and Di Santo J.P. What does it take to make a natural killer?. Nat Rev Immunol 3 (2003) 413-425
4. Yokoyama W.M., Kim S., and French A.R. The dynamic life of natural killer cells. Annu Rev Immunol 22 (2004) 405-429
5. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
6. French A.R., and Yokoyama W.M. Natural killer cells and viral infections. Curr Opin Immunol 15 (2003) 45-51
7. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
8. Costello R.T., Fauriat C., Sivori S., Marcenaro E., and Olive D. NK cells: innate immunity against hematological malignancies?. Trends Immunol 25 (2004) 328-333
9. Kim S., Iizuka K., Kang H.S., Dokun A., French A.R., Greco S., et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3 (2002) 523-528
10. Kim S., Iizuka K., Aguila H.L., Weissman I.L., and Yokoyama W.M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A 97 (2000) 2731-2736
11. Kim S., Song Y.J., Higuchi D.A., Kang H.P., Pratt J.R., Yang L., et al. Arrested natural killer cell development associated with transgene insertion into the Atf2 locus. Blood 107 (2006) 1024-1030
12. Held W., Cado D., and Raulet D.H. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med 184 (1996) 2037-2041
13. Fahlen L., Khoo N.K., Daws M.R., and Sentman C.L. Location-specific regulation of transgenic Ly49A receptors by major histocompatibility complex class I molecules. Eur J Immunol 27 (1997) 2057-2065
14. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9 (1998) 669-676
15. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191 (2000) 771-780
16. Cooper M.A., Bush J.E., Fehniger T.A., VanDeusen J.B., Waite R.E., Liu Y., et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100 (2002) 3633-3638
17. Ranson T., Vosshenrich C.A., Corcuff E., Richard O., Muller W., and Di Santo J.P. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 101 (2003) 4887-4893
18. Prlic M., Blazar B.R., Farrar M.A., and Jameson S.C. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 197 (2003) 967-976
19. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., et al. Coordinated and distinct roles for IFN-alphabeta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169 (2002) 4279-4287
20. French A.R., Sjolin H., Kim S., Koka R., Yang L., Young D.A., et al. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol 177 (2006) 4981-4990
21. Fehniger T.A., Suzuki K., Ponnappan A., VanDeusen J.B., Cooper M.A., Florea S.M., et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med 193 (2001) 219-231
22. Fehniger T.A., Suzuki K., VanDeusen J.B., Cooper M.A., Freud A.G., and Caligiuri M.A. Fatal leukemia in interleukin-15 transgenic mice. Blood Cells Mol Dis 27 (2001) 223-230
23. Tefferi A., Li C.Y., Witzig T.E., Dhodapkar M.V., Okuno S.H., and Phyliky R.L. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 84 (1994) 2721-2725
24. Lima M., Almeida J., Montero A.G., Teixeira Mdos A., Queiros M.L., Santos A.H., et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 165 (2004) 1117-1127
25. Rabbani G.R., Phyliky R.L., and Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 106 (1999) 960-966
26. Orange J.S., Chehimi J., Ghavimi D., Campbell D., and Sullivan K.E. Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b. Clin Immunol 99 (2001) 53-64
27. Okuno S.H., Tefferi A., Hanson C.A., Katzmann J.A., Li C.Y., and Witzig T.E. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells. Br J Haematol 93 (1996) 810-812
28. Oshimi K., Kawa K., Nakamura S., Suzuki R., Suzumiya J., Yamaguchi M., et al. NK-cell neoplasms in Japan. Hematology 10 (2005) 237-245
29. Noguchi M., Yoshita M., Sakai K., Matsumoto Y., Arahata M., Ontachi Y., et al. Peripheral neuropathy associated with chronic natural killer cell lymphocytosis. J Neurol Sci 232 (2005) 119-122
30. Blaser B.W., Roychowdhury S., Kim D.J., Schwind N.R., Bhatt D., Yuan W., et al. Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood 105 (2005) 894-901
31. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., and Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2 (2001) 951-956
32. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-713
33. Andrews D.M., Farrell H.E., Densley E.H., Scalzo A.A., Shellam G.R., and Degli-Esposti M.A. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ?. J Immunol 166 (2001) 1796-1802
34. Dokun A.O., Chu D.T., Yang L., Bendelac A.S., and Yokoyama W.M. Analysis of in situ NK cell responses during viral infection. J Immunol 167 (2001) 5286-5293
35. Morice W.G., Leibson P.J., and Tefferi A. Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis. Leuk Lymphoma 41 (2001) 277-284
36. Wex H., Aumann V., Hausler M., Vorwerk P., and Mittler U. Chronic natural killer cell lymphocytosis is associated with elevated cytotoxic activity of natural killer cells. J Pediatr Hematol Oncol 27 (2005) 85-89
37. Lamy T., and Loughran Jr. T.P. Clinical features of large granular lymphocyte leukemia. Semin Hematol 40 (2003) 185-195
38. Oshimi K. Leukemia and lymphoma of natural killer lineage cells. Int J Hematol 78 (2003) 18-23
39. Kwong Y.L. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 19 (2005) 2186-2194
40. Ruskova A., Thula R., and Chan G. Aggressive Natural Killer-Cell Leukemia: report of five cases and review of the literature. Leuk Lymphoma 45 (2004) 2427-2438
41. Suzuki R., Suzumiya J., Nakamura S., Aoki S., Notoya A., Ozaki S., et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18 (2004) 763-770
42. Cheung M.M., Chan J.K., and Wong K.F. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol 40 (2003) 221-232
43. Ohno Y., Amakawa R., Fukuhara S., Huang C.R., Kamesaki H., Amano H., et al. Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality. Cancer 64 (1989) 63-67
44. De Lord C., Mercieca J., Ashton-Key M., Singh L., Ryley S., Isaacson P., et al. Aggressive NK cell lymphoma preceded by a ten year history of neutropenia associated with large granular lymphocyte lymphocytosis. Leuk Lymphoma 31 (1998) 417-421
45. Huang Q., Chang K.L., Gaal K.K., and Weiss L.M. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder. Am J Surg Pathol 29 (2005) 1540-1543